Stocks Health care PRFX

NASDAQ · Health care

PRF Technologies Ltd. (PRFX)

PRF Technologies Ltd. reported revenue of $17K in fiscal 2025. It posted a net loss of $5M. In fiscal 2025 capital spending exceeded operating cash flow by $4M. At December 31, 2025 it held $3.1M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 26, 2026.

What PRF Technologies Ltd. does

PRF Technologies Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PRFX.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Where PRFX ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What PRF Technologies Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 24, 2026
   Activist stake (5% or more) SCHEDULE 13D
2. September 16, 2026
   Foreign issuer update 6-K
3. September 9, 2026
   Foreign issuer update 6-K
4. September 3, 2026
   Form POS AM filing POS AM
5. September 3, 2026
   Foreign issuer update 6-K
6. July 27, 2026
   Foreign issuer update 6-K
7. July 21, 2026
   Foreign issuer update 6-K
8. July 15, 2026
   Foreign issuer update 6-K
9. July 8, 2026
   Foreign issuer update 6-K
10. June 29, 2026
    Securities offering prospectus 424B3

Recent insider filings (Forms 3, 4 and 144): 7, the latest on March 18, 2026. Insider transactions on SEC

Who owns PRFX

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Latest filings below 5%: Blade Ranger Ltd. 0% (June 16, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about PRFX

What does PRF Technologies Ltd. do?

PRF Technologies Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PRFX.

Is PRF Technologies Ltd. profitable?

No. In fiscal 2025 it reported a net loss of $5M on revenue of $17K.

How much revenue does PRF Technologies Ltd. make?

In fiscal 2025 PRF Technologies Ltd. reported revenue of $17K.

When did PRF Technologies Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 26, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the activist stake (5% or more) from September 24, 2026.

Similar companies

Compare PRFX with

Compare PRFX with any company

Follow PRFX

Get an email when PRF Technologies Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Follow PRFX: get an email when it files

Where the numbers come from

Financial figures are the values PRF Technologies Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.